Physician profile
Bridget B Allen
NPI 1952743726
$2,890.07
in general payments reported to CMS, 2019-2025
7 companies · $192 in 2025
The $192 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $194 · 2023: $143 · 2024: $2,361 · 2025: $192.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,546 · Food and Beverage: $1,031 · Education: $119.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,546.32 |
| Food and Beverage | $1,030.84 |
| Education | $118.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $1,996.71 | 2024 | |
| Glaxosmithkline, LLC. | $271.26 | 2024-2025 | Ojjaara, Jemperli |
| Astrazeneca Pharmaceuticals Lp | $230.48 | 2022-2023 | Lynparza |
| Incyte Corporation | $199.69 | 2022-2024 | Jakafi |
| Novocure INC. | $146.68 | 2025 | Optune Gio |
| Karyopharm Therapeutics INC. | $23.80 | 2023 | Xpovio |
| Genmab U.S., INC. | $21.45 | 2025 | Epkinly |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bridget Allen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.